Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease.
Publication/Presentation Date
12-1-2020
Abstract
In the original article, the Table 1 has published with error.
Volume
11
Issue
12
First Page
3011
Last Page
3013
ISSN
1869-6953
Published In/Presented At
Guja, C., Frías, J. P., Suchower, L., Hardy, E., Marr, G., Sjöström, C. D., & Jabbour, S. A. (2020). Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease. Diabetes therapy : research, treatment and education of diabetes and related disorders, 11(12), 3011–3013. https://doi.org/10.1007/s13300-020-00842-w
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
33011938
Department(s)
Administration and Leadership
Document Type
Article
COinS